The shareholders of both companies have both overwhelmingly backed Merck & Co."s acquisition of Schering-Plough Corp., a deal that allows Merck, the world"s eighth-biggest drugmaker by prescription medicine sales, to jump to second just behind Pfizer. Merck has its asthma and allergy treatment Singulair [montelukast] and cervical cancer vaccine Gardasil while Schering-Plough can contribute its allergy spray Nasonex [mometasone furoate monohydrate] and well known consumer products like Dr Scholl"s foot care.
저작권자 © 메디칼업저버 무단전재 및 재배포 금지